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Abstract: Amyotrophic lateral sclerosis (ALS) is defined by the destruction of upper- and lower
motor neurons. Post-mortem, nearly all ALS cases are positive for cytoplasmic aggregates containing
the DNA/RNA binding protein TDP-43. Recent studies indicate that this pathogenic mislocalization
of TDP-43 may participate in generating hyperexcitability of the upper motor neurons, the earliest
detectable change in ALS patients, yet the mechanisms driving this remain unclear. We investigated
how mislocalisation of TDP-43 could initiate network dysfunction in ALS. We employed a tetracycline
inducible system to express either human wildtype TDP-43 (TDP-43WT) or human TDP-43 that cannot
enter the nucleus (TDP-43∆NLS) in excitatory neurons (Camk2α promoter), crossed Thy1-YFPH mice
to visualize dendritic spines, the major site of excitatory synapses. In comparison to both TDP-43WT
and controls, TDP-43∆NLS drove a robust loss in spine density in all the dendrite regions of the
upper motor neurons, most affecting thin spines. This indicates that TDP-43 is involved in the
generation of network dysfunction in ALS likely through impacting the formation or durability of
excitatory synapses. These findings are relevant to the vast majority of ALS cases, and provides
further evidence that upper motor neurons may need to be protected from TDP-43 mediated synaptic
excitatory changes early in disease.
Keywords: amyotrophic lateral sclerosis; TDP-43; dendrite spine
1. Introduction
Amyotrophic Lateral Sclerosis (ALS) is the most common form of motor neuron
disease. ALS was once believed to be primarily neuromuscular and is now characterized
by a large neurodegenerative component [1]. ALS involves the progressive loss of upper
motor neurons in the motor cortex and lower motor neurons in the spinal cord. This leads
to muscle weakness, muscle loss and eventually death in 3–5 years for most patients [2].
ALS is clinically heterogenous, a heterogeneity which can be effectively correlated to degree
of upper and lower motor neuron burden [3,4]. Multiple disease mechanisms have been
implicated in ALS and it is highly likely to be multifactorial in mechanism [5,6]. Insufficient
understanding of the cause of ALS or how pathology progresses through the neuromotor
system has hampered the development of effective therapeutics.
Upper motor neurons play an integral role in ALS pathophysiology. One of the
earliest detectable clinical markers of ALS is motor cortex hyperexcitability [7,8]. This
increased firing of upper motor neurons within the motor cortex precedes any changes in
lower motor neurons [8]. This indicates that the excitability changes may spread through
synaptic connections of the corticomotor system network and affect the health of lower
motor neurons through glutamate excitotoxicity [9]. Evidence for network dysfunction in
ALS can be further demonstrated by intracortical facilitation, a proxy measurement for
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excitatory synaptic input, which is increased, and short-interval intracortical inhibition (a
proxy measurement for inhibitory input), which is decreased [10], suggesting that synaptic
mechanisms contribute to altered excitability in ALS. In line with this, studies in models
of ALS and post-mortem tissue indicate that synaptic disruption is a conserved feature of
ALS [11–16]. However, whilst ALS features synaptic dysfunction and the progressive loss
of neurons in distinct anatomical networks; the events initiating these pathological events
are still unknown.
Familial ALS has been associated with a number of inherited genetic mutations
including C9orf72, TDP-43, SOD1 and FUS as some of the most common [17]. However,
this familial inheritance of a predisposition to disease only accounts for 10% of total ALS
cases. The majority of ALS patients (90%) have no known genetic cause. Despite this, more
than 95% of all ALS cases have accumulation of the DNA/RNA binding protein Tar DNA
Binding protein of 43kDa (TDP-43) in the cytoplasm of neurons within the corticomotor
system [18,19]. This implies that the mislocalization of TDP-43 is critical to the progression
of ALS irrespective of mutation status of the person living with ALS. Recent discoveries
now link wild-type TDP-43 pathology with hyperexcitability in the motor cortex [20,21].
These studies have provided the bridge between the most frequent pathology of ALS and
a conserved pathophysiological presentation of the disease, highlighting the potential
importance of TDP-43 mislocalization. However, how these changes commence in people
with ALS remains to be fully elucidated.
Therefore, the current study interrogated how TDP-43 mislocalization, the precursor
to the main pathology of ALS, affects excitatory synapses in a mouse model of pathogeneti-
cally mislocalized TDP-43 through the analysis of dendritic spines. Dendritic spines are
small, dynamic protrusions from the shaft of dendrites [22]. The dendritic spine contains
the postsynaptic molecular machinery that enables synaptic transmission and plasticity,
functionally compartmentalising intracellular chemical and electrical signalling [23]. Neo-
cortical neurons such as upper motor neurons have a highly structured dendritic tree
which traverses the laminar of the neocortex, with spine inputs dependent upon the lam-
inar the which spine resides [24,25]. Dendritic spines also exhibit a wide range of sizes
and shapes within a single dendritic section, which can be categorized as thin or mush-
room/stubby [26]. This regional and structural organization enables the sophisticated
fine tuning of neuronal excitability that spine populations are constantly achieving. To
investigate if dendritic spines are altered in upper motor neurons with the presence of
mislocalized TDP-43, we utilized two inducible mouse models of TDP-43 that express
wildtype human (TDP-43WT) and mislocalized human TDP-43 (TDP-43∆NLS) in forebrain
neurons using the Camk2α promoter [27]. The TDP-43∆NLS mouse model expresses TDP-43
which accumulates in the cytoplasm and causes endogenous TDP-43 to be lost from the
nucleus, as occurs in most cases of ALS [27]. The total levels of TDP-43 in the TDP-43∆NLS
brain are higher than that in TDP-43WT, presumably due to impaired regulation of the
TDP-43 in the cytoplasm [27]. We analysed these mice at post-natal day 60, with 30 days
of induced transgene expression, a timepoint which we have previously shown is before
extensive neuron loss [20]. To quantify the density of spines in the primary motor cortex
the TDP-43WT and TDP-43∆NLS mice were crossed with Thy1-YFPH mice, which express
fluorescent protein in layer V neurons in the cortex [28]. We analysed different spine
morphologies in different compartments of upper motor neurons, which are the main
excitatory output for the motor cortex.
2. Materials and Methods
2.1. Mouse Cohort
All experiments were approved by the Animal Ethics Committee of the University of
Tasmania (#A16593) in accordance with the Australian Code of Practice for the Care and
Use of Animals for Scientific Purposes (2013). Mice were housed in individually ventilated
cage at 20 ◦C on a 12-h light—dark cycle with ad libitum access to food and water. All
mice strains were purchased from Jackson Laboratories (Bar Harbor, USA). Heterozygous
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Thy1-YFP transgenic mice (B6.Cg-Tg(Thy1-YFP)HJrs/J/ Stock No: 003782) [28,29] were
crossed with previously described Camk2α-tTa (B6;CBA-Tg(Camk2a-tTA)1Mmay/Stock
No: 003010). Mice heterozygous for Thy1-YFP and Camk2α-tTa were bred with tetO-TDP-
43∆NLS (B6;C3-Tg(tetO-TARDBP*)4Vle/J/Stock No: 014650) and tetO-TDP-43WT mice
(B6;C3-Tg(tetO-TARDBP)12Vle/J/Stock No: 016841) [20,27]. These strains have inducible
expression of TDP-43 with the removal of doxycycline from their diet. The breeders were
provided chow containing 200 mg/kg doxycycline at least 1 week before mating and their
offspring remained on the doxycycline diet before being switched to standard chow at
postnatal day 30 (P30). All mice were fully backcrossed to the C57Bl6/J background strain
prior to the commencement of experiments. Mono-transgenic Thy1-YFP-H were from a
separate mouse cohort and did not deceive doxycycline. Three groups of animals were
included in the study, triple transgenic Camk2a-tTA:tetO-TARDBP12:Thy1-YFP-H mice
termed TDP-43WT, triple transgenic Camk2a-tTA:tetO-TARDBP4:Thy1-YFP-H mice termed
TDP-43∆NLS and mono transgenic Thy1-YFP-H termed WT. All mice were aged P60 at the
time of tissue processing, mice of both sexes were used in the current experiments.
2.2. Tissue Processing
Mice were terminally anesthetised with an overdose of sodium pentobarbitone (Jurox,
Sydney, Australia) delivered with an intraperitoneal injection and transcardially perfused
with 4% (w/v) paraformaldehyde (PFA, Electron Microscopy Sciences, Hatfield, PA, USA)
in 0.01 M phosphate-buffered saline (PBS, Sigma Aldrich, St Louis, MO, USA). Brains were
removed and post-fixed in 4% PFA overnight at 4 ◦C and stored in PBS containing 0.1%
sodium azide.
Brains were dissected and cut on the coronal axis at bregma −4.00 mm. The rostral
segment was embedded in 5% agarose for sectioning. Then, 40 µm coronal sections were
sectioned using a Leica VT100S vibratome (Wetzlar, Germany). Free-floating sections were
collected and stored in 24 well plates containing 0.1% sodium azide in PBS and stored at
4 ◦C until required for immunohistochemistry.
2.3. Immunohistochemistry
Coronal sections containing primary motor cortex [30] were collected from each
animal. Free floating sections were first washed twice for ten minutes in 0.01 M PBS before
a blocking solution containing 1% normal goat serum and 0.3% triton-X (Sigma Aldrich
USA) in 0.01 M PBS was added for one hour. Sections were incubated with anti-GFP
antibody (1:2000, Nacalai Tesque, Cat# 04404-84, Kyoto, Japan), anti-hTDP-43 antibody
(1:1000 Proteintech Cat# 60019-2-Ig, Rosemont, IL, USA) diluted in 0.3% Triton-X in 0.01 M
PBS. Sections were washed three times for ten minutes in PBS before being incubated with
anti-rat AlexaFluor 488 secondary antibody, anti-mouse AlexaFluor 568 secondary antibody
and DAPI (Invitrogen, Boston, MA, USA) for 90 min. All incubations were performed at
21 ◦C. Sections were mounted onto slides and coverslipped with PermaFluor (Boston, MA,
USA) aqueous mounting media.
2.4. Microscopy
Immunofluorescent images were captured using an UltraView Nikon Ti spinning
disk confocal microscope with Volocity software (Perkin Elmer, Boston, MA, USA). A low
magnification objective (20×) was used to determine the location of the motor cortex. For
TDP-43 localisation, the objective was switched to a higher magnification (40×, N/A 0.95)
objective and images with z-spacing of 1 µm were collected. For spine quantification the
objective was switched to a high magnification (60× N/A 1.2) water immersion objective
and images with z-spacing of 0.5 µm were collected. Standard excitation and emission filters
were used. Images of basal dendrites attached to the cell body were taken of pyramidal
neurons in layer V of the primary motor cortex (Figure 1). The objective was moved to
layer II/III, identified through an increased density of nuclei between the YFP cell bodies of
layer V and layer I, and images were taken of the apical dendrites (Figure 1). The objective
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was then moved to layer I, identified due to its proximity to the surface and images were
taken of apical tuft dendrites (Figure 1). Three-dimensional image rendering with volume
and surface rendering added was performed in Imaris 9.2.0 (Zurich, Switzerland).
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(MBF Bioscience, Burlington, MA, USA). Individual basal, apical and apical tuft dendrites 
were traced through z-stacks and their spines labelled as either thin or mushroom spines 
depending on the spine head size [31]. Stubby spines were classed as mushroom shaped, 
and filopodial spines were classed as thin spines. Data files were then exported to Neuro-
lucida explorer 11 (MBF Bioscience, Burlington, MA USA) for quantification. Branched 
structure analysis was used to determine the density and ratio of each spine type. Basal 
dendrites were analysed according to branch order, with branch order 1 dendrites being 
directly attached to a layer V pyramidal cell soma. Branch order 1 dendrites were ex-
cluded from the analysis as these had variable length but very few spines, basal dendrite 
analysis included branch order 2 and above.  
2.6. Statistical Analysis 
Basal dendrite data of n = 5 for WT and n = 3 for TDP-43WT and TDP-43ΔNLS were 
summed for each separate mouse and using G*Power [32] it was determined that these 
mouse numbers were sufficiently powered for the current dataset and we commenced the 
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Figure 1. Illustration of a Layer V YFP-H positive neuron within the motor cortex. Three different
regions were included for spine quantification (red boxes). All apical tuft dendrites were quantified
in layer I, identified by the clearly visible meninges membrane. Apical dendrites within cortical
layer II/III were identified through location of the cortical layers and only the main apical dendrite
included in quantification. Basal dendrites in layer V w re identified as directly co nected to a YFP-H
pyra i al iti spines on the entire vis ble dendritic tree were counted from a single
somatic branch point. Scale bars 50 µM.
2.5. Quantification
Dendritic spine density quantification was performed using Neurolucida software
(MBF Bioscience, Burlington, MA, USA). Individual basal, apical and apical tuft dendrites
were traced through z-stacks and their spines labelled as either thin or mushroom spines
depending on the spine head size [31]. Stubby spines were classed as mushroom shaped,
and filopodial spines were classed as thin spines. Data files were then exported to Neu-
rolucida explorer 11 (MBF Bioscience, Burlington, MA USA) for quantification. Branched
structure analysis was used to determine the density and ratio of each spine type. Basal
dendrites were analysed according to branch order, with branch order 1 dendrites being
directly attached to a layer V pyramidal cell soma. Branch order 1 dendrites were excluded
from the analysis as these had variable length but very few spines, basal dendrite analysis
included branch order 2 and above.
2.6. Statistical Analysis
Basal dendrite data of n = 5 for WT and n = 3 for TDP-43WT and TDP-43∆NLS were
summed for each separate mouse and using G*Power [32] it was determined that these
mouse numbers were sufficiently powered for the current dataset and we commenced the
rest of the analysis. Data was analysed per dendrite using GraphPad Prism version 9 (San
Diego, CA, USA). All data is represented as the mean ± standard error of the mean, each
datapoint represents an individual dendrite. Data was checked for normality and where
the data sets passed the normal distribution assumption (majority), one way analysis of
variance (ANOVA) with a post hoc Bonferroni correction for multiple comparisons was
used. In the apical data set the TDP-43∆NLS group did not demonstrate sufficient evidence
for normal distribution assumption and the Kruskal–Wallis one-way ANOVA was used
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for this data set with a Dunn’s multiple comparison. A p-value of <0.05 was considered
statistically significant.
3. Results
Here, we utilise two inducible mouse models of TDP-43 expression. The TDP-43WT
and TDP-43∆NLS mouse models express hTDP-43 in forebrain neurons utilising the Camk2α
promoter. TDP-43WT mice express full length human TDP-43 with no mutation, whereas
TDP-43∆NLS mice express TDP-43 with a mutated nuclear localisation sequence, causing
TDP-43 to accumulate in the cytoplasm. Expression in these models is controlled by the
presence of doxycycline in the diet of the mice. For these experiments, doxycycline was
removed from the diet at post-natal day 30 (P30), inducing expression of the TDP-43
transgene for 30 days until experiments occurred at P60. These mice were crossed with
Thy1-YFPH mice, which express fluorescent protein in layer V neurons in the cortex. Using
immunohistochemistry directed that YFP and human TDP-43, we identified that human
TDP-43 expression was restricted to the nucleus in the TDP-43WT mice of all YFP cells
visualized (Figure 2B), whereas in TDP-43∆NLS mice human TDP-43 was predominantly
cytoplasmic and excluded from the nucleus in all YFP positive cells visualized in this model
(Figure 2C,D).
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Figure 2. TDP-43 localization within the motor cortex. (A). Example of WT Layer V neurons within the motor cortex
that are positive for YFP (green) and DAPI (blue), with no human TDP-43 (red) labelling present. (B). TDP-43WT Layer
V neurons within the motor cortex were positive for YFP (green), human TDP-43 (red) and DAPI (blue), with human
TDP-43 labelling nuclear (arrows) (merged). (C). TDP-43∆NLS Layer V neurons within the motor cortex were positive for
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(merged). (D). Three-dimensional representation of a YFP neuron (green) with TDP-43 (red) wrapping around the DAPI
nucleus (blue). Scale bar, A-C = 50 µm, D = 20 µm.
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3.1. Expression of Mislocalised TDP-43 Caused a Loss of Spines in Apical Tuft Dendrites
Neurons receive highly compartmentalised synaptic inputs. Apical tuft dendrites of
layer V pyramidal neurons branch off the thick apical dendrite in layer I. The synapses
on apical tufts of upper motor neurons are electrically isolated from the cell body and
receive a broad range of inputs from long range cortical connections and feedback from the
thalamus [33,34]. The density of spines was measured in apical tuft dendrites in WT, TDP-
43WT and TDP-43∆NLS mice (Figure 3A). The total density of spines in apical tuft dendrites
was reduced in TDP-43∆NLS neurons by >44% compared to both WT and TDP-43WT
neurons (Figure 3B). The frequency of spine density further shows clear alterations between
TDP-43∆NLS and the WT and TDP-43WT controls with a 49% change in median density
(Figure 3C). Overall, this data indicates that TDP-43∆NLS expression is affecting total spine
density in the apical tuft dendrites of Layer V pyramidal neurons of the motor cortex. The
characterisation of spines as either thin or mushroom has important synaptic physiological
implications. Mushroom spines are a more mature type, generally having a greater number
of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor complex (AMPA) and
N-methyl-D-aspartate (NMDA) receptors [35]. This means that synapses onto mushroom
spines are more readily able to depolarise the membrane than synapses onto thin type
spines [36]. When the morphology of spines was assessed, a decrease in mushroom spine
density of >29% was detected in TDP-43∆NLS apical tuft dendrites (Figure 3D), while thin
spines were also reduced in TDP-43∆NLS apical tuft dendrites by 54% (Figure 3E). The
greater loss of thin spines caused a reduction in the proportion of thin spines in apical
tuft dendrites in TDP-43∆NLS mice (Figure 3F). This indicates that mislocalised TDP-43 is
driving a dramatic decrease in the thin, immature spines of apical tuft dendrites.
3.2. The Density of Spines Is Reduced in Apical Trunk Dendrites in TDP-43∆NLS Neurons
Apical trunk dendrites were identified as the thick, projecting dendrites of layer V
pyramidal neurons in the motor cortex (Figure 1). Apical trunk dendrites receive inputs
from local circuits and layer IV neurons of the motor cortex [24]. Images were taken in
the layer II/III region of these dendrites and the density of spines was determined in WT,
TDP-43WT and TDP-43∆NLS neurons. The total density of spines in apical trunk dendrites
was reduced by >44% in TDP-43∆NLS neurons compared to WT and TDP-43WT neurons
(Figure 4B). The frequency distribution of spine density shows a robust leftward shift
(loss) of spine density in the apical trunk dendrites of TDP-43∆NLS neurons compared to
WT and TDP-43WT neurons (Figure 4C). There was no significant difference in total spine
density between WT and TDP-43WT neurons. When spine type was examined, >31% of
mushroom spines were lost on the apical trunk of in TDP-43∆NLS neurons compared to
both WT and TDP-43WT neurons (Figure 4D), while thin spines were decreased by almost
50% (Figure 4E). Because of this increased loss of thin spines, there was a corresponding
decrease in the proportion of thin spines that were observed on apical trunk dendrites of
TDP-43∆NLS neurons (Figure 4F).
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3.3. The Density of Spines Is Reduced in Basal Dendrites in TDP-43∆NLS Neurons
Basal dendrites were identified as protruding from a layer V pyramidal neuron soma
and spines were counted from an entire visible dendritic tree stemming from a single
somatic branch point (Figure 5A). Basal dendrites of layer V pyramidal neurons in the
motor cortex primarily receive inputs from layer IV neurons and local circuits [24]. The
density of spines in basal dendrites was reduced in TDP-43∆NLS neurons by >55% compared
to both WT and TDP-43WT neurons (Figure 5B). The frequency distribution of spines on
the basal dendrites of TDP-43∆NLS neurons shows a left shift in spine density (Figure 5C).
The density of mushroom and thin spines on basal dendrites were reduced by >40% and
>65%, respectively, in TDP-43∆NLS neurons (Figure 5D,E). Once again, the exacerbated loss
of thin spines meant that there was an increase in the proportion of mushroom spines in
basal neurons (Figure 5F).
3.4. Changes to Dendritic Spines Were Dependent on the Localisation of TDP-43 but Not the
Location of the Dendritic Spine
Regional analysis of dendritic spine density following 30 days of expression of TDP-
43∆NLS, in comparison to TDP-43WT expression and wild-type controls, revealed a dramatic
loss of spines throughout the dendritic tree of the upper motor neurons. There were
no significant differences in the proportion of total, mushroom or thin spine densities
compared to WT in TDP-43WT or TDP-43∆NLS layer V excitatory neurons between the
basal, apical or apical tuft regions (Figure 6A). Together, these data suggest that with
wild-type TDP-43, it is the mislocalisation of TDP-43 to the cytoplasm which is important
for spineopathy in ALS (Figure 6B).
Brain Sci. 2021, 11, 883 10 of 16
Brain Sci. 2021, 11, x FOR PEER REVIEW 11 of 18 
 
 
Figure 5. TDP-43∆NLS layer V pyramidal motor neuron basal dendrites have reduced spine density. (A). Example images
of basal dendrites from WT, TDP-43WT and TDP-43∆NLS layer V pyramidal neurons of the motor cortex (scale bar 30um,
inset 7.5 um). (B). Spine density was reduced in TDP-43∆NLS basal dendrites compared to both WT and TDP-43WT neurons
(F(2,38) = 45.9, p < 0.0001). (C). Frequency distribution of spine density shows significant leftward shift (decreased spine
density) of TDP-43∆NLS basal dendrites. Dotted lines show the median. (D). There was a reduced density of mushroom
spines in TDP-43∆NLS basal dendrites compared to WT (F(2,38) = 13.3, p = 0.0003) and TDP-43WT (p < 0.0001). (E). TDP-
43∆NLS basal dendrites have reduced density of thin spines to both WT and TDP-43WT neurons (F(2,38) = 40.1, p < 0.0001).
(F). TDP-43∆NLS basal dendrites have a reduced proportion of thin spines (F = 8.57(2,38), p = 0.0105 to WT and p = 0.0009 to
TDP-43WT). * p < 0.05, *** p < 0.001, **** p < 0.0001, one-way ANOVA with Bonferroni multiple comparisons.
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Figure 6. Importance of TDP-43 localisation on dendritic spine density. (A). Table showing the percentage difference for
mushroom, thin and total spines compared to wild-type of TDP-43WT and TDP-43∆NLS dendrites (One-way ANOVA with
Bonferroni multiple comparisons - Mushroom F(2,107) = 0.79, p = 0.454, Thin F(2,107) = 1.20, p = 0.303, Total F(2,107) = 1.37,
p = 0.258) (B). Illustration highlighting the importance of TDP-43 localisation on spine density in the upper motor neuron.
In TDP-43∆NLS mice, there was a robust loss of spines in apical tuft, apical and basal dendrites. This loss of spines occurred
in both mushroom and thin spines, where thin spines were more severely affected. Overexpression of wild-type TDP-43
did not cause any significant spine changes in upper motor neurons suggesting that it is the localisation, rather than the
expression levels of TDP-43 which are important for spineopathy in ALS.
4. Discussion
ALS is a currently incurable disease that causes selective degeneration of the corti-
comotor system. It remains to be elucidated why motor neurons, which are some of the
largest in the nervous system, are selectively vulnerable in this disease [37]. However, it
is highly likely that, similar to many neurodegenerative diseases, a significant period of
neuronal dysfunction occurs prior to frank cell loss, contributing to both the initiation and
propagation of neuronal death in the corticomotor system [38,39]. Whilst how neuronal
dysfunction arises in ALS is not known, it is becoming apparent that upper motor neuron
dysfunction is a critical factor in ALS [2]. The most likely disease profile of an ALS patient is
no known genetic mutation, focal motor cortex hyperexcitability which has the propensity
to cause widespread network dysfunction and TDP-43 protein which is excluded from the
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motor neuron nucleus [10,19]. How these critical disease profiles interact is only starting
to be comprehended [13,20] and how these changes result ultimately in neuronal demise
remains an important research question. Therefore, we endeavoured to interrogate whether
TDP-43 mislocalization contributes to the generation of upper motor neuron dysfunction
through altering neuronal circuitry. We investigated the role of mislocalised TDP-43 at the
dendritic spine by employing an inducible model, in which TDP-43 that cannot enter the
nucleus is expressed in layer V pyramidal neurons (on the CamkIIα promoter) within the
motor cortex; crossed with the Thy-1 YFP-H mouse to visualize dendritic spines.
Excitatory synapses can be elegantly investigated at the dendritic spine—the structural
and functional representation of the vast majority of excitatory synapses in the brain [36].
Spines are the site for synaptic transmission and plasticity, functionally compartmentalising
intracellular chemical and electrical signalling [40]. Spine loss and dendrite pathology is
observed in upper motor neurons of ALS patient post-mortem tissue [16,41]. This spine loss
has been replicated in preclinical models and shown to be a consistent feature of familial
mouse models of ALS at symptomatic time points [42]. The most widely characterized
model of familial ALS, the mutant SOD1G93A mouse model, demonstrates progressive
spine loss [43]. This is also replicated in the mutant TDP-43A315T model of ALS [14]. Whilst
these contributions highlight the importance of spine changes in ALS, it is unclear if they
are specific to the mutant protein and hence associated with the relevant familial form
of ALS. Here, we determined that TDP-43 mislocalisation could drive changes in spine
density, addressing the underrepresented non-familial ALS cohorts in past studies. We
discovered that following 30 days expression of mislocalized TDP-43 there is a significant
loss of spines in upper motor neurons in comparison to both controls and wildtype human
TDP-43 expressing mice. This data validates the functional loss of spontaneous- and
mini-excitatory post-synaptic currents previously reported in TDP-43NLS layer V cortical
motor neurons in the same model at the same time points [20]. This is consistent with
other mouse models of familial ALS, namely SOD1 and FUS, which also have a loss of
dendritic spines, but lack TDP-43 pathology [19,44,45]. Furthermore, spine loss has been
observed with TDP-43 mutation, where this form of TDP-43 is also present outside the
nucleus [14,46]. This suggests that spine loss is a critical step in the progression of ALS [19].
Previously, we have shown that there is no neuron loss in the motor cortex in the TDP-43WT
or TDP-43∆NLS mouse models [20], suggesting that dendritic spines changes occur prior
to neuron death. We quantified distinct anatomical regions and observed that dendritic
spine loss was widespread, and not restricted to a specific neuronal compartment. Thus,
both long-range and local synaptic inputs are uniformly lost in upper motor neurons in
TDP-43∆NLS mice.
In ALS, neuronal loss in the motor cortex is observed post-mortem [16,47] yet the
degree of TDP-43 aggregation may not reflect the degree of cell loss [48]. This may be
because the neurons that accumulate TDP-43 in the cytoplasm selectively degenerate and
die over the course of the disease. Furthermore, the extent of TDP-43 mislocalisation
in the motor cortex is controversial [49,50]. For instance, antibodies commonly used in
human studies that target only pTDP-43 show only protein aggregation, not the nuclear
or cytoplasmic TDP-43 that is soluble [48]. Further studies are necessary to determine if
mislocalisation of soluble TDP-43 is having a pathogenic effect prior to and potentially
independent of TDP-43 aggregation. TDP-43 localises to synaptic vesicles both under
normal conditions [51,52] and in the anterior horn of the spinal cords of human ALS
patients [53]. Here, we show that upper motor neuron spine alterations occur when TDP-43
is mislocalised to the cytoplasm, however, the TDP-43∆NLS mouse does have increased
cortical levels of TDP-43 than TDP-43WT, so the increased load of TDP-43 in TDP-43∆NLS
could also contribute to spine alterations.
Increases in TDP-43 within the cytoplasmic compartment affects spine density, an
effect that is more pronounced in thin spines. Whilst the functional relevance of morpho-
logical spine types is unclear [54], evidence suggests that thin spine types are immature,
transient and highly motile [55]. This immaturity and motility is critical for the establish-
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ment of new connections, which through the recruitment of more synaptic machinery,
namely the AMPA receptors, can then develop into the more mature, dense, mushroom
spines [56]. Previous research has identified that TDP-43 can transcriptionally regulate
components of AMPA receptors [57,58] and that the pathogenic mislocalisation of TDP-43
in this model decreases the expression of the AMPA receptor subunits Gria 1–3 [20]. This
could potentially affect the formation of mushroom spines and the maturation of thin
spines. Future studies investigating spine plasticity and maturation are warranted to
answer these research questions.
Upper motor neuron hyperexcitability is the first physiological change to be detected
in ALS patients [3,39] and has been hypothesised to underlie the spread of pathology from
the upper motor neurons to the lower motor neurons in the spinal cord; termed the ‘die
forward hypothesis’ [9,59]. Changes in neuronal excitability in ALS are measured using
transcranial magnetic stimulation (TMS). TMS produces electrical currents to stimulate the
primary motor cortex and muscle response can then be measured. Using TMS, studies have
shown patients in the early stages of ALS require a smaller stimulus to generate a motor
response, indicating hyperexcitable upper motor neurons [8,60]. Preclinical research has
offered insight into the mechanisms of the hyperexcitable motor cortex in ALS. Direct elec-
trophysiological recordings can be made from upper motor neurons expressing different
disease-causing proteins. Previous studies in the SOD1G93A mouse model at certain time
points [13,61], the TDP-43A315T mouse model [15] and the current TDP-43∆NLS model [20]
have all reported that layer V pyramidal neurons in the motor cortex are hyperexcitable,
consistent with clinical findings. The relationship between layer V cortical motor neuron
hyperexcitability and dendritic spine loss is not yet known, but it is highly likely that
homeostatic mechanisms are at play. Thus, it is possible that the spine loss identified in
the current study, and in other models, may contribute to the initiation and progression
of increased upper motor neuron excitability. To perform useful information processing
neurons must integrate a range of inputs to an appropriate output. When synaptic inputs
dramatically change, intrinsic excitability is homeostatically regulated to allow suitable
responsiveness to synaptic inputs. Previous studies using whisker trimming and auditory
deprivation to generate loss of synaptic input have shown this decreased synaptic input
can drive increases in intrinsic excitability to maintain functional output [62–64]. Therefore,
it is possible that spine loss may result in increased intrinsic excitability, through an over-
compensation leading to the hyperexcitability which has been observed in the TDP-43∆NLS
motor cortex at the same timepoint as the current experiments [20]. However, it is also
plausible that the converse may be happening, that increased intrinsic excitability occurs
first leading to a maladaptive down regulation of spine formation [65,66]. Irrespective
of whether synaptic or intrinsic excitability changes occur first, we hypothesise that such
dramatic changes in excitatory synaptic inputs (~50% reduction) or intrinsic excitability [20]
result in homeostatic changes aimed at maintaining neuronal output; but that homeostatic
failure ultimately leads to a hypersensitivity to excitatory synaptic inputs. Such failures
of the homeostatic control systems could occur via a maladaptive feedback response to
perturbations, altered set-point regulation or sensor impairment [67]. Finally, it is also
feasible that TDP-43 mislocalisation may mediate direct independent effects on intrinsic
excitability and dendritic spines due to the role of TDP-43 in splicing [50]. Regardless of
whether spine loss is the cause or consequence of intrinsic excitability changes, spine loss
in upper motor neurons is a critical and early feature of ALS progression in models of ALS.
5. Conclusions
We have identified that TDP-43 mislocalization causes a loss of 44–50% of dendritic
spines in upper motor neurons regardless of whether these spines were located on basal,
apical or apical tuft dendrites. Furthermore, there was a more pronounced loss of thin
spines compared to mushroom spines across all dendrite regions. Collectively, these data
show that TDP-43 mislocalisation, the most common pathological hallmark in ALS, can
cause spine loss and potentially inhibit the formation of new spines in upper motor neurons
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in ALS. Future therapeutics could look at targeting either the dendritic spine, or the spine
in combination with mislocalisation of TDP-43 in upper motor neurons.
Author Contributions: Conceptualization, M.S.D. and C.A.B.; methodology, M.S.D., A.W. and C.A.B.;
software, M.S.D. and C.A.B.; validation, A.W. and C.A.B.; formal analysis, M.S.D.; investigation,
M.S.D. and C.A.B.; resources, C.A.B.; data curation, M.S.D. and C.A.B.; writing—original draft
preparation, M.S.D.; writing—review and editing, A.W. and C.A.B.; visualization, M.S.D. and C.A.B.;
supervision, A.W. and C.A.B.; project administration, C.A.B.; funding acquisition, C.A.B. All authors
have read and agreed to the published version of the manuscript.
Funding: This research was funded by MND Research Australia, Betty Laidlaw Prize and Dementia
Australia, Project Grant. M.D. is supported by Tasmanian Masonic Medical Research Foundation
and MND Research Australia and C.A.B. by Australian Research Council (DECRA).
Institutional Review Board Statement: The study was conducted according to the guidelines of the
Declaration of Helsinki, and approved by the Animal Ethics Committee of the University of Tasmania
(#A16593).
Data Availability Statement: The datasets generated in the present study are available from the
corresponding author upon reasonable request.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Hardiman, O. Major advances in amyotrophic lateral sclerosis in 2020. Lancet Neurol. 2021, 20, 14–15. [CrossRef]
2. Shibuya, K.; Park, S.B.; Geevasinga, N.; Menon, P.; Howells, J.; Simon, N.G.; Huynh, W.; Noto, Y.I.; Götz, J.; Kril, J.J.; et al. Motor
cortical function determinesprognosis in sporadic ALS. Neurology 2016, 87, 513–520. [CrossRef] [PubMed]
3. Dharmadasa, T. Cortical Excitability across the ALS Clinical Motor Phenotypes. Brain Sci. 2021, 11, 715. [CrossRef]
4. Ravits, J.P.; Jorg, C.P. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007, 68,
1571–1575. [CrossRef]
5. Ragagnin, A.M.; Shadfar, S.; Vidal, M.; Jamali, M.S.; Atkin, J.D. Motor Neuron Susceptibility in ALS/FTD. Front. Neurosci. 2019,
13, 532. [CrossRef] [PubMed]
6. Kiernan, M.C.; Vucic, S.; Talbot, K.; McDermott, C.J.; Hardiman, O.; Shefner, J.M.; Al-Chalabi, A.; Huynh, W.; Cudkowicz, M.;
Talman, P.; et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2021, 17, 104–118. [CrossRef]
[PubMed]
7. Menon, P.; Higashihara, M.; van den Bos, M.; Geevasinga, N.; Kiernan, M.C.; Vucic, S. Cortical hyperexcitability evolves with
disease progression in ALS. Ann. Clin. Transl. Neurol. 2020, 7, 733–741. [CrossRef] [PubMed]
8. Menon, P.; Kiernan, M.C.; Vucic, S. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin. Neurophysiol.
2015, 126, 803–809. [CrossRef]
9. Eisen, A. The Dying Forward Hypothesis of ALS: Tracing Its History. Brain Sci. 2021, 11, 300. [CrossRef] [PubMed]
10. Vucic, S.; Cheah, B.C.; Yiannikas, C.; Kiernan, M.C. Cortical excitability distinguishes ALS from mimic disorders. Clin. Neurophys-
iol. 2011, 122, 1860–1866. [CrossRef] [PubMed]
11. Fogarty, M.J.; Klenowski, P.M.; Lee, J.D.; Drieberg-Thompson, J.R.; Bartlett, S.E.; Ngo, S.T.; Hilliard, M.A.; Bellingham, M.C.;
Noakes, P.G. Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral
sclerosis. Sci. Rep. 2016, 6, 37968. [CrossRef]
12. Fogarty, M.J.; Noakes, P.G.; Bellingham, M.C. Motor cortex layer V pyramidal neurons exhibit dendritic regression, spine loss,
and increased synaptic excitation in the presymptomatic hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. J. Neurosci.
2015, 35, 643–647. [CrossRef]
13. Saba, L.; Viscomi, M.T.; Caioli, S.; Pignataro, A.; Bisicchia, E.; Pieri, M.; Molinari, M.; Ammassari-Teule, M.; Zona, C. Altered
Functionality, Morphology, and Vesicular Glutamate Transporter Expression of Cortical Motor Neurons from a Presymptomatic
Mouse Model of Amyotrophic Lateral Sclerosis. Cereb. Cortex 2016, 26, 1512–1528. [CrossRef]
14. Handley, E.E.; Pitman, K.A.; Dawkins, E.; Young, K.M.; Clark, R.M.; Jiang, T.C.; Turner, B.J.; Dickson, T.C.; Blizzard, C.A. Synapse
Dysfunction of Layer V Pyramidal Neurons Precedes Neurodegeneration in a Mouse Model of TDP-43 Proteinopathies. Cereb.
Cortex 2017, 27, 3630–3647. [CrossRef]
15. Zhang, W.; Zhang, L.; Liang, B.; Schroeder, D.; Zhang, Z.W.; Cox, G.A.; Li, Y.; Lin, D.T. Hyperactive somatostatin interneurons
contribute to excitotoxicity in neurodegenerative disorders. Nat. Neurosci. 2016, 19, 557–559. [CrossRef]
16. Hammer, R.; Tomiyasu, U.; Scheibel, A. Degeneration of the Human Betz Cell Due to Amyotrophic Lateral Sclerosis. Exp. Neurol.
1979, 63, 336–346. [CrossRef]
17. Ghasemi, M.; Brown, R.H., Jr. Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb. Perspect Med. 2018, 8, 1465–1470.
[CrossRef]
Brain Sci. 2021, 11, 883 15 of 16
18. Neumann, M.S.; Kwong, D.M.; Truax, L.K.; Micsenyi, A.C.; Chou, M.C.; Bruce, T.T.; Schuck, J.; Grossman, T.; Clark, M.;
McCluskey, C.M.; et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science
2006, 314, 130–133. [CrossRef]
19. Ling, S.C.; Polymenidou, M.; Cleveland, D.W. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis.
Neuron 2013, 79, 416–438. [CrossRef] [PubMed]
20. Dyer, M.S.; Reale, L.A.; Lewis, K.E.; Walker, A.K.; Dickson, T.C.; Woodhouse, A.; Blizzard, C.A. Mislocalisation of TDP-43 to the
cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex. J. Neurochem. 2020.
[CrossRef] [PubMed]
21. Weskamp, K.; Tank, E.M.; Miguez, R.; McBride, J.P.; Gómez, N.B.; White, M.; Lin, Z.; Gonzalez, C.M.; Serio, A.; Sreedharan, J.; et al.
Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS. J. Clin. Investig. 2020, 130,
1139–1155. [CrossRef] [PubMed]
22. Yu, X.; Zuo, Y. Spine plasticity in the motor cortex. Curr. Opin. Neurobiol. 2011, 21, 169–174. [CrossRef] [PubMed]
23. Holtmaat, A.; Svoboda, K. Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci. 2009,
10, 647–658. [CrossRef] [PubMed]
24. Spruston, N. Pyramidal neurons: Dendritic structure and synaptic integration. Nat. Rev. Neurosci. 2008, 9, 206–221. [CrossRef]
[PubMed]
25. Williams, S.R.; Stuart, G.J. Role of dendritic synapse location in the control of action potential output. Trends Neurosci. 2003, 26,
147–154. [CrossRef]
26. Berry, K.P.; Nedivi, E. Spine Dynamics: Are They All the Same? Neuron 2017, 96, 43–55. [CrossRef]
27. Igaz, L.M.; Kwong, L.K.; Lee, E.B.; Chen-Plotkin, A.; Swanson, E.; Unger, T.; Malunda, J.; Xu, Y.; Winton, M.J.; Trojanowski, J.Q.;
et al. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J. Clin. Investig. 2011,
121, 726–738. [CrossRef]
28. Porrero, C.; Rubio-Garrido, P.; Avendaño, C.; Clascá, F. Mapping of fluorescent protein-expressing neurons and axon pathways in
adult and developing Thy1-eYFP-H transgenic mice. Brain Res. 2010, 1345, 59–72. [CrossRef]
29. Feng, G.; Mellor, R.H.; Bernstein, M.; Keller-Peck, C.; Nguyen, Q.T.; Wallace, M.; Nerbonne, J.M.; Lichtman, J.W.; Sanes, J.R.
Imaging Neuronal Subsetsin Transgenic Mice ExpressingMultiple Spectral Variants of GFP. Neuron 2000, 28, 41–51. [CrossRef]
30. Paxinos, G.; Franklin, K. The Mouse Brain in Stereotaxic Coordinates; Academic Press: Cambridge, MA, USA, 2007.
31. Pchitskaya, E.; Bezprozvanny, I. Dendritic Spines Shape Analysis-Classification or Clusterization? Perspective. Front. Synaptic
Neurosci. 2020, 12, 31. [CrossRef]
32. Faul, F.; Erdfelder, E.; Buchner, A.; Lang, A.G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression
analyses. Behav. Res. Methods 2009, 41, 1149–1160. [CrossRef]
33. Phillips, W.A. Cognitive functions of intracellular mechanisms for contextual amplification. Brain Cogn. 2017, 112, 39–53.
[CrossRef]
34. Rubio-Garrido, P.; Pérez-de-Manzo, F.; Porrero, C.; Galazo, M.J.; Clascá, F. Thalamic input to distal apical dendrites in neocortical
layer 1 is massive and highly convergent. Cereb. Cortex 2009, 19, 2380–2395. [CrossRef] [PubMed]
35. Yuste, R.; Majewska, A.; Holthoff, K. From form to function: Calcium compartmentalization in dendritic spines. Nat. Neurosci.
2000, 3, 653–659. [CrossRef]
36. Sala, C.; Segal, M. Dendritic spines: The locus of structural and functional plasticity. Physiol. Rev. 2014, 94, 141–188. [CrossRef]
37. Fogarty, M.J. The bigger they are the harder they fall: Size-dependent vulnerability of motor neurons in amyotrophic lateral
sclerosis. J. Physiol. 2018, 596, 2471–2472. [CrossRef]
38. Ravits, J.M.; La Spada, A.R. ALS motor phenotype heterogeneity, focality, and spread. Neurology 2009, 73, 805–811. [CrossRef]
[PubMed]
39. Vucic, S.; Nicholson, G.A.; Kiernan, M.C. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis.
Brain 2008, 131 Pt 6, 1540–1550. [CrossRef]
40. Tonnesen, J.; Nagerl, V.U. Dendritic Spines as Tunable Regulators of Synaptic Signals. Front. Psychiatry 2016, 7, 101. [CrossRef]
[PubMed]
41. Genç, B.; Jara, J.H.; Lagrimas, A.K.; Pytel, P.; Roos, R.P.; Mesulam, M.M.; Geula, C.; Bigio, E.H.; Özdinler, P.H. Apical dendrite
degeneration, a novel cellular pathology for Betz cells in ALS. Sci. Rep. 2017, 7, 41765. [CrossRef] [PubMed]
42. Pradhan, J.; Bellingham, C.M. Neurophysiological Mechanisms Underlying Cortical Hyper-Excitability in Amyotrophic Lateral
Sclerosis: A Review. Brain Sci. 2021, 11, 549. [CrossRef] [PubMed]
43. Fogarty, M.J.; Mu, E.W.; Lavidis, N.A.; Noakes, P.G.; Bellingham, M.C. Motor Areas Show Altered Dendritic Structure in an
Amyotrophic Lateral Sclerosis Mouse Model. Front. Neurosci. 2017, 11, 609. [CrossRef] [PubMed]
44. Sephton, C.F.; Tang, A.A.; Kulkarni, A.; West, J.; Brooks, M.; Stubblefield, J.J.; Liu, Y.; Zhang, M.Q.; Green, C.B.; Huber, K.M.; et al.
Activity-dependent FUS dysregulation disrupts synaptic homeostasis. Proc. Natl. Acad. Sci. USA 2014, 111, E4769–E4778.
[CrossRef] [PubMed]
45. Fogarty, M.J.; Mu, E.W.; Noakes, P.G.; Lavidis, N.A.; Bellingham, M.C. Marked changes in dendritic structure and spine density
precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1(G93A) mouse model of
amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2016, 4, 77. [CrossRef] [PubMed]
Brain Sci. 2021, 11, 883 16 of 16
46. Jiang, T.; Handley, E.; Brizuela, M.; Dawkins, E.; Lewis, K.E.; Clark, R.M.; Dickson, T.C.; Blizzard, C.A. Amyotrophic lateral
sclerosis mutant TDP-43 may cause synaptic dysfunction through altered dendritic spine function. Dis. Model. Mech. 2019, 12.
[CrossRef]
47. Murayama, S.; Bouldin, T.; Suzuki, K. Immunocytochemical and ultrastructural studies of upper motor neurons in amyotrophic
lateral sclerosis. Acta Neuropathol. 1992, 83, 518–524. [CrossRef]
48. Braak, H.; Ludolph, A.C.; Neumann, M.; Ravits, J.; Del Tredici, K. Pathological TDP-43 changes in Betz cells differ from those in
bulbar and spinal alpha-motoneurons in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2017, 133, 79–90. [CrossRef]
49. Kawakami, I.; Arai, T.; Hasegawa, M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol.
2019, 138, 751–770. [CrossRef] [PubMed]
50. Hergesheimer, R.C.; Chami, A.A.; de Assis, D.R.; Vourc’h, P.; Andres, C.R.; Corcia, P.; Lanznaster, D.; Blasco, H. The debated toxic
role of aggregated TDP-43 in amyotrophic lateral sclerosis: A resolution in sight? Brain 2019, 142, 1176–1194. [CrossRef]
51. Wang, I.F.; Wu, L.S.; Chang, H.Y.; Shen, C.K.J. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J.
Neurochem. 2008, 105, 797–806. [CrossRef]
52. Liu-Yesucevitz, L.; Bassell, G.J.; Gitler, A.D.; Hart, A.C.; Klann, E.; Richter, J.D.; Warren, S.T.; Wolozin, B. Local RNA translation at
the synapse and in disease. J. Neurosci. 2011, 31, 16086–16093. [CrossRef]
53. Sasaki, S.; Takeda, T.; Shibata, N.; Kobayashi, M. Alterations in subcellular localization of TDP-43 immunoreactivity in the
anterior horns in sporadic amyotrophic lateral sclerosis. Neurosci. Lett. 2010, 478, 72–76. [CrossRef]
54. Ofer, N.; Berger, D.R.; Kasthuri, N.; Lichtman, J.W.; Yuste, R. Ultrastructural analysis of dendritic spine necks reveals a continuum
of spine morphologies. Dev. Neurobiol. 2021. [CrossRef]
55. Holtmaat, A.J.; Trachtenberg, J.T.; Wilbrecht, L.; Shepherd, G.M.; Zhang, X.; Knott, G.W.; Svoboda, K. Transient and persistent
dendritic spines in the neocortex in vivo. Neuron 2005, 45, 279–291. [CrossRef]
56. Nakahata, Y.; Yasuda, R. Plasticity of Spine Structure: Local Signaling, Translation and Cytoskeletal Reorganization. Front.
Synaptic Neurosci. 2018, 10, 29. [CrossRef]
57. Narayanan, R.K.; Mangelsdorf, M.; Panwar, A.; Butler, T.J.; Noakes, P.G.; Wallace, R.H. Identification of RNA bound to the TDP-43
ribonucleoprotein complex in the adult mouse brain. Amyotroph. Lateral Scler. Front. Degener. 2013, 14, 252–260. [CrossRef]
[PubMed]
58. Sephton, C.F.; Cenik, C.; Kucukural, A.; Dammer, E.B.; Cenik, B.; Han, Y.; Dewey, C.M.; Roth, F.P.; Herz, J.; Peng, J.; et al.
Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem. 2011, 286, 1204–1215.
[CrossRef] [PubMed]
59. Geevasinga, N.; Menon, P.; Özdinler, P.H.; Kiernan, M.C.; Vucic, S. Pathophysiological and diagnostic implications of cortical
dysfunction in ALS. Nat. Rev. Neurol. 2016, 12, 651–661. [CrossRef]
60. Vucic, S.; Kiernan, M.C. Axonal excitability properties in amyotrophic lateral sclerosis. Clin. Neurophysiol. 2006, 117, 1458–1466.
[CrossRef] [PubMed]
61. Saba, L.; Viscomi, M.T.; Martini, A.; Caioli, S.; Mercuri, N.B.; Guatteo, E.; Zona, C. Modified age-dependent expression of NaV1.6
in an ALS model correlates with motor cortex excitability alterations. Neurobiol. Dis. 2019, 130, 104532. [CrossRef] [PubMed]
62. Jamann, N.; Dannehl, D.; Lehmann, N.; Wagener, R.; Thielemann, C.; Schultz, C.; Staiger, J.; Kole, M.H.; Engelhardt, M. Sensory
input drives rapid homeostatic scaling of the axon initial segment in mouse barrel cortex. Nat. Commun. 2021, 12, 23. [CrossRef]
[PubMed]
63. Kuba, H.; Oichi, Y.; Ohmori, H. Presynaptic activity regulates Na(+) channel distribution at the axon initial segment. Nature 2010,
465, 1075–1078. [CrossRef]
64. Breton, J.D.; Stuart, G.J. Loss of sensory input increases the intrinsic excitability of layer 5 pyramidal neurons in rat barrel cortex.
J. Physiol. 2009, 587 Pt 21, 5107–5119. [CrossRef]
65. Turrigiano, G.G.; Leslie, K.R.; Desai, N.S.; Rutherford, L.C.; Nelson, S.B. Activity-dependent scaling of quantal amplitude in
neocortical neurons. Nature 1998, 391, 892–896. [CrossRef] [PubMed]
66. Siddoway, B.; Hou, H.; Xia, H. Molecular mechanisms of homeostatic synaptic downscaling. Neuropharmacology 2014, 78, 38–44.
[CrossRef] [PubMed]
67. Styr, B.; Slutsky, I. Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer’s disease. Nat.
Neurosci. 2018, 21, 463–473. [CrossRef] [PubMed]
